ATE343399T1 - Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte - Google Patents

Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte

Info

Publication number
ATE343399T1
ATE343399T1 AT01273668T AT01273668T ATE343399T1 AT E343399 T1 ATE343399 T1 AT E343399T1 AT 01273668 T AT01273668 T AT 01273668T AT 01273668 T AT01273668 T AT 01273668T AT E343399 T1 ATE343399 T1 AT E343399T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
enhancement
drug effects
drug
effective amount
Prior art date
Application number
AT01273668T
Other languages
English (en)
Inventor
Sergey Serdyuk
Original Assignee
Gevys Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gevys Pharmaceuticals Ltd filed Critical Gevys Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE343399T1 publication Critical patent/ATE343399T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01273668T 2001-02-05 2001-12-19 Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte ATE343399T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/775,794 US6833377B2 (en) 2001-02-05 2001-02-05 Composition and method for potentiating drugs

Publications (1)

Publication Number Publication Date
ATE343399T1 true ATE343399T1 (de) 2006-11-15

Family

ID=25105521

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01273668T ATE343399T1 (de) 2001-02-05 2001-12-19 Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte

Country Status (11)

Country Link
US (1) US6833377B2 (de)
EP (1) EP1359939B1 (de)
AT (1) ATE343399T1 (de)
AU (1) AU2002219417B2 (de)
CA (1) CA2437351A1 (de)
DE (1) DE60124144T2 (de)
DK (1) DK1359939T3 (de)
ES (1) ES2275624T3 (de)
IL (2) IL157226A0 (de)
PT (1) PT1359939E (de)
WO (1) WO2002062388A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192220A1 (en) * 2001-02-05 2005-09-01 Gevys Pharmaceuticas Ltd. Composition and method for potentiating drugs
US9877921B2 (en) 2005-09-09 2018-01-30 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20070059361A1 (en) * 2005-09-09 2007-03-15 University Of Manitoba Fast-disintegrating epinephrine tablets for buccal or sublingual administration
US20160045457A1 (en) 2005-09-09 2016-02-18 Ousama Rachid Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine
WO2007143676A2 (en) * 2006-06-05 2007-12-13 Verus Pharmaceuticals, Inc. Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
TW200816985A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
US20080108970A1 (en) * 2006-11-08 2008-05-08 Viertio-Oja Hanna E Control of Drug Administration
US8729070B2 (en) * 2008-02-20 2014-05-20 Targia Pharmaceuticals CNS pharmaceutical compositions and methods of use
CA2716080C (en) * 2008-02-20 2016-12-13 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
US20120322884A1 (en) 2010-03-01 2012-12-20 University Of Manitoba Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
US20140242177A1 (en) 2011-10-21 2014-08-28 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
CA3169368A1 (en) 2012-06-15 2014-01-09 Nova Southeastern University Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
PL2976072T3 (pl) 2013-03-22 2021-11-22 Nova Southeastern University Drobne cząstki epinefryny i sposoby ich stosowania do leczenia chorób reagujących na epinefrynę
WO2016027259A1 (en) * 2014-08-21 2016-02-25 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
US20190343780A1 (en) * 2016-12-22 2019-11-14 Rvx Therapeutics Ltd. Low dose drug combinations for use in preventing and treating neuronal damage
US20220347122A1 (en) * 2019-03-15 2022-11-03 Ftf Pharma Private Limited Solutions for oral dosage

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947579A (en) 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
DE3321969A1 (de) 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4843071A (en) 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
US4788189A (en) 1988-02-29 1988-11-29 Glazer Howard I Method to treat smoking withdrawal symptoms by potentiated central noradrenergic blocking
US5431922A (en) 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5891842A (en) 1993-04-09 1999-04-06 Trustees Of Tufts College Methodology for eliciting an analgesic response in a living subject
CA2134038C (en) 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
EP0714663A3 (de) 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
AU706541B2 (en) 1995-06-09 1999-06-17 Euro-Celtique S.A. Formulations and methods for providing prolonged local anesthesia
US6511987B1 (en) 1999-11-12 2003-01-28 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds

Also Published As

Publication number Publication date
PT1359939E (pt) 2007-02-28
US6833377B2 (en) 2004-12-21
EP1359939A1 (de) 2003-11-12
ES2275624T3 (es) 2007-06-16
DE60124144T2 (de) 2007-09-06
US20030004134A1 (en) 2003-01-02
DK1359939T3 (da) 2007-02-26
DE60124144D1 (de) 2006-12-07
WO2002062388A1 (en) 2002-08-15
CA2437351A1 (en) 2002-08-15
EP1359939B1 (de) 2006-10-25
IL157226A0 (en) 2004-02-19
AU2002219417B2 (en) 2007-03-22
IL157226A (en) 2010-11-30

Similar Documents

Publication Publication Date Title
ATE343399T1 (de) Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte
TNSN08140A1 (de)
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
MXPA03008756A (es) Derivados de n-(arilsulfonil) beta-aminoacidos que comprenden un grupo aminometilo substituido, el metodo de preparacion de los mismos y las composiciones farmaceuticas que los contienen.
SE0100568D0 (sv) Compounds
EA200700362A1 (ru) Конъюгат, содержащий антивирусное соединение, в частности ингибирующее вич, фармацевтическая композиция и набор стандартной дозы лекарственного препарата на его основе, способ ингибирования с его помощью
TW200510375A (en) New compounds
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
ATE432279T1 (de) Tricyclische delta-opioid-modulatoren
PT1119543E (pt) N-aralquilaminotetralinas como ligandos para o receptor y5 do neuropeptido y
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
AR032293A1 (es) Estuche farmaceutico
FI962735A0 (fi) 2-hydroksi-5-fenylatsobensoehapon johdannaisten käyttö paksusuolen syövän kemialliseen ehkäisyyn ja kemoterapeuttisena aineena
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
EA200700403A1 (ru) ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
ATE342264T1 (de) Indolderivate und deren verwendung als gnrh antagonisten
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
ATE389402T1 (de) Sedierende nicht-benzodiazepin-formulierungen
SE0101692D0 (sv) Compounds
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1359939

Country of ref document: EP

REN Ceased due to non-payment of the annual fee